Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma The following represents disclosure information provided by ...
Within contemporary biochemical discourse, increasing attention has been directed toward peptide fragments that retain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results